The Austrian Broadcasting Corporation (ORF) Portrayed “The Future Makers” at Fresenius Kabi Austria

July 25, 2022

What is produced in Graz and Werndorf? How does the working day look like? What does Fresenius Kabi Austria stand for? These questions and many more were the subject of the ORF film shoot for a new episode of the TV series, "Die Zukunftsmacher - Menschen in der Industrie," (The future makers - people in the industry) to present Styrian companies and provide insights into their craft.

Our plant manager Ruth Staubmann and two employees, Jenny Mitteregger, laboratory technician, and Helmut Pelzmann, lean manager, answered the questions and shared their views on what working at Fresenius Kabi Austria means to them personally. The film shoot took place right on the spot: in production and in the laboratory in Graz, as well as in the packaging and logistics center in Werndorf, 15 minutes away.

“It was a unique and exciting experience for us to be part of this film production showing the audience which contribution we make every day for our patients by manufacturing essential medical products to help them get well again or to improve their quality of life. It's a wonderful and fulfilling feeling," says plant manager Ruth Staubmann.

Watch the film here: Die Zukunftsmacher - Fresenius Kabi Austria

Additional insights 

Die Zukunftsmacher

With over 100,000 employees, Styrian industry is one of the largest employers in the country. In "The Future Makers", "Styria Today" introduces people in industry every second Tuesday.

Fresenius Kabi Austria

Around 1,500 employees at Fresenius Kabi Austria develop, produce, and distribute lifesaving medicines for national and international markets. They provide patients with affordable, state-of-the-art therapies for their medical needs. On site, for example, biosimilar products are packaged and distributed globally. Every day more than 400,000 products manufactured in Graz are used in healthcare institutions worldwide and more than 160 million drugs, such as anesthetics, analgesics, antibiotics and clinical nutrition solutions, are shipped from Fresenius Kabi plant annually. Currently, an investment project of more than €60 million is further expanding operations and is scheduled for completion in 2023.